These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 32694162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.
    Block GA, Pergola PE, Fishbane S, Martins JG, LeWinter RD, Uhlig K, Neylan JF, Chertow GM.
    Nephrol Dial Transplant; 2019 Jul 01; 34(7):1115-1124. PubMed ID: 30380116
    [Abstract] [Full Text] [Related]

  • 4. Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia.
    Ito K, Akizawa T, Arita K, Mitobe Y, Komatsu N.
    Clin Exp Nephrol; 2024 Jul 01; 28(7):636-646. PubMed ID: 38402503
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
    Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J.
    Clin J Am Soc Nephrol; 2014 Apr 01; 9(4):705-12. PubMed ID: 24458078
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial.
    Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL.
    JAMA; 2017 Jun 13; 317(22):2297-2304. PubMed ID: 28609534
    [Abstract] [Full Text] [Related]

  • 10. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.
    Clin Nephrol; 2014 Jun 13; 81(6):419-26. PubMed ID: 24691014
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.
    Bielesz B, Lorenz M, Monteforte R, Prikoszovich T, Gabriel M, Wolzt M, Gleiss A, Hörl WH, Sunder-Plassmann G.
    Clin J Am Soc Nephrol; 2021 Oct 13; 16(10):1512-1521. PubMed ID: 34470831
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA, Keating GM.
    Drugs; 2009 Oct 13; 69(6):739-56. PubMed ID: 19405553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
    Iguchi A, Yamamoto S, Yamazaki M, Tasaki K, Suzuki Y, Kazama JJ, Narita I.
    Clin Exp Nephrol; 2018 Aug 13; 22(4):789-796. PubMed ID: 29181658
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of intravenous and oral iron in chronic kidney disease.
    Agarwal R, Kusek JW, Pappas MK.
    Kidney Int; 2015 Oct 13; 88(4):905-14. PubMed ID: 26083656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.